MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Background Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the m...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Vol. 126; no. 19; pp. 4423 - 4431
Main Authors: Elad, Sharon, Cheng, Karis Kin Fong, Lalla, Rajesh V., Yarom, Noam, Hong, Catherine, Logan, Richard M., Bowen, Joanne, Gibson, Rachel, Saunders, Deborah P., Zadik, Yehuda, Ariyawardana, Anura, Correa, Maria Elvira, Ranna, Vinisha, Bossi, Paolo, Arany, Praveen, Al‐Azri, Abdul Rahman, Blijlevens, Nicole, Hovan, Allan, Fregnani, Eduardo, Fulton, Janet, Gueiros, Luiz Alcino, Rouleau, Tanya, Coller, Janet K., Al‐Dasooqi, Noor, Wardill, Hannah, Ameringer, Suzanne, Antunes, Héliton Spindola, Bateman, Emma H., Bektas, Kivanc, Bensadoun, René‐Jean, Ten Bohmer, K., Brito‐Dellan, Norman, Castillo, Daniel, Chiang, Karen, de Mooij, Charlotte, Eilers, June, Epstein, Joel, Galiti, Dimitra, Fall‐Dickson, Jane M., Gobbo, Margherita, Issa Hazboun, Hanan, Jensen, Siri Beier, Johansen, Jorgen, Joy, Jamie, Joy, K., Kandwal, Abhishek, Kataoka, Tomoko, Keefe, Dorothy, Loprinzi, Charles L., Lubart, Rachel, Skripnik Lucas, Anna, Majorana, Alessandra, Mayo, Bronwen, Mori, Takehiko, Nair, Raj G., Nasr, Narmin, Nicolatou‐Galitis, Ourania, Ottaviani, Giulia, Migliorati, Cesar, Pentenero, Monica, Porcello, Lorraine, Peterson, Douglas, Potting, Carin, Raber‐Durlacher, Judith, van Sebille, Ysabella Z. A., Soga, Yoshihiko, Sonis, Stephen, Stringer, Andrea M., Thorpe, Daniel, Tilly, Vanessa, Tissing, Wim, Toro, Juan J., Treister, Nathaniel Simon, Vaddi, Anusha, Weikel, Dianna, van de Wetering, Marianne, Zur, Eyal
Format: Journal Article
Language:English
Published: United States Wiley Subscription Services, Inc 01.10.2020
John Wiley and Sons Inc
Subjects:
ISSN:0008-543X, 1097-0142, 1097-0142
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis. Methods The literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. Results The guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions. Conclusions The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting‐specific, evidence‐based tool to help with the management of mucositis in patients who have cancer. The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology developed clinical practice guidelines for the management of mucositis, with the first edition published in 2004 and periodically updated. This summary presents the 2019/2020 guidelines update, which is based on a systematic review, and generates a tool that will help clinicians to select evidence‐based interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Instructional Material/Guideline-3
content type line 23
ObjectType-Undefined-4
The MASCC/ISOO Mucositis Guidelines are developed to facilitate the evidence‐based management of mucositis. Clinicians should also use their own judgment in making treatment decisions for individual patients. The guideline authors and the MASCC/ISOO do not guarantee or take responsibility for clinical outcomes in individual patients.
The members of the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) include: Praveen Arany, Abdul Rahman Al‐Azri, Nicole Blijlevens, Allan Hovan, Eduardo Fregnani, Janet Fulton, Luiz Alcino Gueiros, Tanya Rouleau, Janet K. Coller, Noor Al‐Dasooqi, and Hannah Wardill. Other contributors include (in alphabetic order): Suzanne Ameringer, Héliton Spindola Antunes, Emma H. Bateman, Kivanc Bektas, René‐Jean Bensadoun, K. Ten Bohmer, Norman Brito‐Dellan, Daniel Castillo, Karen Chiang, Charlotte de Mooij, June Eilers, Joel Epstein, Dimitra Galiti, Jane M. Fall‐Dickson, Margherita Gobbo, Hanan Issa Hazboun, Siri Beier Jensen, Jorgen Johansen, Jamie Joy, K. Joy, Abhishek Kandwal, Tomoko Kataoka, Dorothy Keefe, Charles L. Loprinzi, Rachel Lubart, Anna Skripnik Lucas, Alessandra Majorana, Bronwen Mayo, Charlotte de Mooij, Takehiko Mori, Raj G. Nair, Narmin Nasr, Ourania Nicolatou‐Galitis, Giulia Ottaviani, Cesar Migliorati, Monica Pentenero, Lorraine Porcello, Douglas Peterson, Carin Potting, Judith Raber‐Durlacher, Ysabella Z. A. van Sebille, Yoshihiko Soga, Stephen Sonis, Andrea M. Stringer, Daniel Thorpe, Vanessa Tilly, Wim Tissing, Juan J. Toro, Nathaniel Simon Treister, Anusha Vaddi, Dianna Weikel, Marianne van de Wetering, and Eyal Zur.
ISSN:0008-543X
1097-0142
1097-0142
DOI:10.1002/cncr.33100